Table 1. Clinical, biochemical and instrumental characteristics of the population.
| Variables N patients = 35 | Mean value | Standard deviation |
|---|---|---|
| Age (years) | 9.52 | 3.35 |
| Height (cm) | 140.94 | 18.47 |
| Weight (Kg) | 55.37 | 22.27 |
| Body Mass Index (Kg/m2) | 26.59 | 5.21 |
| Body Mass Index (percentiles) | 92.6 | 7.69 |
| Systolic blood pressure (mmHg) | 101.71 | 11.44 |
| Diastolic blood pressure (mmHg) | 67.29 | 8.77 |
| Fasting glucose (mg/dl) | 86.43 | 6.89 |
| HOMAir | 3.49 | 1.95 |
| D-Dimers (ng/ml) | 391.93 | 221.06 |
| FBG (mg/dl) | 280.43 | 46.09 |
| vWFAg (%) | 89.19 | 21.81 |
| ET-1 (pg/ml) | 3.69 | 1.6 |
| AD (µg/ml) | 5.41 | 1.26 |
| HMW (µg/ml) | 2.75 | 1.31 |
| FMD (%) | 7.38 | 2.22 |
| APAO (cm) | 1.34 | 0.2 |
| C-IMT (mm) | 0.47 | 0.06 |
AD: adiponectin; APAO: antero-posterior diameter of infrarenal abdominal diameter; C-IMT: carotid intima-media thickness; FBG: fibrinogen; FMD: flow mediated vasodilatation; HMW: high molecular weight adiponectin; HOMAir: homeostatic model assessment; ET-1: endothelin-1; vWFAg: vonWillebrand factor antigen.